CHEK2 and breast carcinoma: As there were no cases of lobular invasive breast cancer among the 31 biallelic CHEK2 PV carriers, it was not possible to determine an overall odds ratio (OR) for developing any type of breast cancer (lobular invasive, ductal invasive, and DCIS).